7 in stock
5-Amino-1MQ 10 mg is a small-molecule NNMT inhibitor
attracting research interest for its potential influence on
NAD+, fat-cell metabolism, mitochondrial energy
and metabolic efficiency.
5-Amino-1MQ is short for 5-amino-1-methylquinolinium. It is a
selective inhibitor of nicotinamide N-methyltransferase, commonly
called NNMT.
NNMT plays a role in nicotinamide metabolism, cellular energy and
fat-tissue biology. Therefore, researchers are studying whether
NNMT inhibition can change how cells store and use energy.
NNMT appears to act as an important metabolic regulator.
Increased NNMT activity has been linked to changes in fat storage,
NAD+ metabolism and insulin response.
As a result, blocking NNMT may preserve more nicotinamide for the
NAD+ salvage pathway. This pathway helps cells produce
and recycle NAD+.
5-Amino-1MQ targets an enzyme involved in nicotinamide
and cellular-energy metabolism.
NNMT inhibition may leave more nicotinamide available
for NAD+ production.
Greater NAD+ availability may support
mitochondrial and cellular-energy processes.
Early laboratory and animal studies have produced encouraging
findings. For example, researchers have reported several notable
changes in metabolic models.
Based on its mechanism and early findings, 5-Amino-1MQ is being
explored across several connected areas of metabolic research.
NNMT inhibition may help fat cells use energy more
efficiently. Meanwhile, it may also affect pathways linked
to fat storage.
Preclinical reductions in fat mass and adipocyte size
make body composition a compelling area for continued
research.
NAD+ supports many cellular functions.
Consequently, preserving nicotinamide may help researchers
study mitochondrial energy.
Early findings suggest NNMT inhibition may influence
glucose tolerance and insulin response. However, further
research is still required.
Many metabolic compounds focus on appetite, digestion or
stimulant-driven energy. In contrast, 5-Amino-1MQ targets an
enzyme inside the cell.
Rather than acting mainly through appetite control, it is being
studied for its possible effect on how adipose tissue stores and
uses energy. Because of this, its mechanism stands apart from many
common metabolic research pathways.
The NNMT pathway is often studied alongside other areas of
metabolic and cellular-energy research. For further context,
browse the Canada Biogenix
Weight Management & Metabolism research collection
.
In addition, researchers interested in the NAD+
pathway can explore
NAD+ 500 mg
.
However, combination research remains preliminary. Controlled
human studies have not yet established specific compound
combinations.
The available findings are promising. However, published
evidence for 5-Amino-1MQ remains mainly laboratory- and
animal-based.
Therefore, continued research is needed to learn whether these
effects translate to human biology. Human safety, effectiveness
and long-term outcomes have not been established.
5-Amino-1MQ represents a promising direction in NNMT,
NAD+ and metabolic research. Early studies suggest
potential effects on fat-cell size, body composition, cellular
energy and glucose regulation.
Furthermore, its mechanism does not appear to rely mainly on
appetite suppression. Its distinct pathway and encouraging
preclinical findings make it a compelling compound for continued
scientific study.
Research Use Only
This product is intended exclusively for laboratory research.
Not for human consumption, therapeutic use or veterinary use.
The information presented is educational and does not constitute
medical advice.
